Academic Visitor / Research Associate
Secondment to investigate the mechanism of action of Pulmocide compounds in vivo, ex vivo, in vitro, and to determine host-pathogen interactions contributing to airway remodelling. - Determine the mechanism of action of Pulmocide compounds using primary human patient samples and cutting-edge ex vivo precision cut live lung slice imaging technology in mice.- Focus on the interaction between Aspergillus and the alveolar macrophage during treatment with Pulmocide compounds- Perform in vivo studies on Aspergillus infected mice to determine the immunomodulatory impact of Pulmocide compounds on Aspergillus clearance from the lung.- Design of CRISPR strategies for gene editing in Aspergillus species- Explore microbial infection models to determine altered regulation of pathways involved in airway remodelling and fibrosis of the lung.- Utilising monolayer and 3D co-culture models (bronchospheres) to observe pro-fibrotic signalling events mediated by Aspergillus and Candida infection- In vivo studies in mice using chronic pathogen exposure models to investigate fibrosis and determine potential therapeutic strategies- Immunocytochemistry of lung tissue from chronic lung disease models to measure infection associated fibrotic events